Orbimed Capital LLC, Director at Repare Therapeutics Inc. (RPTX), sold 29,114 shares at $34.52 ($993K) on 2021-08-26, disclosed to the SEC on 2021-08-30.
Open-market sale of $993k RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.52 | 126 | $4K | 0.4% |
| 2 | $34.52 | 4,157 | $143K | 14.5% |
| 3 | $34.52 | 4,157 | $144K | 14.5% |
| 4 | $33.94 | 209 | $7K | 0.7% |
| 5 | $33.94 | 6,884 | $234K | 23.5% |
| 6 | $33.94 | 6,884 |
| $234K |
| 23.5% |
| 7 | $33.92 | 197 | $7K | 0.7% |
| 8 | $33.92 | 6,500 | $220K | 22.2% |
| Total | $34.10 avg | 29,114 | $993K | 100% |
| Filing → |
| PRLD | BUY | 2023-05-24 | $10.0M | — | Filing → |
| ARQT | SELL | 2022-04-08 | $25.4M | — | Filing → |
| RPTX | SELL | 2021-08-25 | $1.2M | — | Filing → |